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Objectives: This study draws on advances in Doppler ultrasound bubble sizing to investigate whether high vo-
lumes of macro-bubbles entering the brain during cardiac surgery increase the risk of new cerebral microbleeds
(CMBs), ischemic MR lesions, or post-operative cognitive decline (POCD).
Methods: Transcranial Doppler (TCD) ultrasound recordings were analysed to estimate numbers of emboli and
macrobubbles (> 100 μm) entering the brain during cardiac surgery. Logistic regression was used to explore the
hypothesis that emboli characteristics affect the incidence of new brain injuries identified through pre- and post-
operative MRI and neuropsychological testing.
Results: TCD, MRI, and neuropsychological test data were compared between 28 valve and 18 CABG patients.
Although valve patients received over twice as many emboli per procedure [median: 1995 vs. 859, p = .004],
and seven times as many macro-bubbles [median: 218 vs. 28, p= .001], high volumes of macrobubbles were not
found to be significantly associated with new CMBs, new ischaemic lesions, or POCD. The odds of acquiring new
CMBs increased by approximately 5% [95% CI: 1 to 10%] for every embolus detected in the first minute after the
release of the aortic cross-clamp (AxC). Logistic regression models also confirmed previous findings that car-
diopulmonary bypass time and valve surgery were significant predictors for new CMBs (both p = .03). Logistic
regression analysis estimated an increase in the odds of acquiring new CMBs of 6% [95% CI: 1 to 12%] for every
minute of bypass time over 91 mins.
Conclusions: This small study provides new information about the properties and numbers of bubbles entering
the brain during surgery, but found no evidence to substantiate a direct link between large numbers of mac-
robubbles and adverse cognitive or MR outcome.
Clinical Trial Registration URL - http://www.isrctn.com. Unique identifier: 66022965.
1. Introduction
In previous research, we showed that 76% of patients undergoing
cardiac surgery with cardiopulmonary bypass (CPB) received new
cerebral microbleeds (CMBs) [1], 31% of patients received new is-
chemic lesions [2], and 46% of patients experienced post-operative
cognitive decline (POCD) [1,2]. The main aim of this study was to ex-
plore the hypothesis that bubbles entering the brain circulation during
surgery might contribute to the pathogenesis of new CMBs, ischemic
lesions, or POCD. Although extensive research has failed to identify any
strong link between bubbles and POCD [3], the pathophysiology of
CMBs is relatively unexplored. No previous studies have attempted to
relate the characteristics of bubbles (size and cumulative volume of air)
to neuroimaging outcomes. Evidence from human and animal models
suggests that bubbles have the potential to aggravate inflammatory
responses, resulting in complement activation, which reduces blood-
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brain barrier integrity allowing leakage of blood into the tissue [4]. In
our previous study, surgery-related CMBs were found in 76% of patients
following cardiac surgery [1], but the pathophysiology leading to the
development of these surgery-related CMBs remains the subject of de-
bate [5]. This sub-study explores whether bubbles received during
surgery are implicated in the pathogenesis of post-operative CMBs.
Our research utilises a bubble sizing algorithm to estimate the sizes
of bubbles and overall volume of air reaching the middle cerebral artery
(MCA) territories during surgery [6]. The feasibility of sizing bubbles
intraoperatively, and imaging findings from this study have been re-
ported elsewhere [1,2,7]. The main aim of this sub-study was to de-
termine whether total bubble volume, or a high incidence of macro-
bubbles (defined as bubbles greater than 0.1 mm in diameter) were
associated with new CMBs, ischemic lesions, or POCD.
2. Patients and methods
All patients undergoing coronary artery bypass grafting (CABG)
and/or cardiac valve surgery at the University Hospitals of Leicester
NHS Trust were eligible for inclusion. For the purposes of neu-
ropsychological testing, patients were excluded if their first language
was not English. The study was approved by the UK Clinical Research
Network (ISRCTN ID: 66022965), the University Hospitals of Leicester
NHS Trust, and Derbyshire Research Ethics Committee (REC reference:
10/H0401/78), and was sponsored by the University of Leicester.
2.1.1. Anaesthetic and surgical procedures
All patients received routine perioperative care with arterial blood
pressure targets based on usual clinical practice. Non-pulsatile cardio-
pulmonary bypass (CPB) with a non-occlusive roller pump was used to
maintain a perfusion pressure of at least 50 mmHg. The CPB circuit
included a membrane oxygenator and a 40 μm arterial line filter.
Surgeons employed a variety of methods, including palpation and fine-
needle aspiration, to reduce emboli released during cannulation and
expel air from the cardiac chambers prior to weaning from bypass. The
Trendelenburg position was adopted for all patients. No aortic filters or
embolus capture devices were employed. On some occasions the sur-
geon would gently agitate the heart to dislodge air from underneath the
valve leaflets and trabeculae, bringing any air to the surface of the
chambers. In patients with severe aortic calcification, distal arch can-
nulation was adopted to help avoid the release of solid emboli.
2.1.2. Transcranial Doppler (TCD) embolus detection
To detect emboli (solid and gaseous) entering the MCA territories,
intra-operative TCD monitoring was performed bilaterally using a
commercially available TCD system equipped with a pair of 2 MHz
transducers (DWL Doppler-BoxTM, Compumedics GmbH, Germany).
Doppler signals were analysed by a blinded observer using ‘in house’
software developed in MATLAB (The Mathworks Inc., Natick, MA).
Candidate embolic signals> 7 dB above the average background in-
tensity were automatically identified as peaks within the recording, and
manually assessed by a highly experienced observer (CB, NP) according
to recommended embolus detection criteria [8]. During analysis of very
dense embolic showers it became impossible to distinguish individual
emboli, and only the duration of the shower could be recorded.
2.1.3. Estimating bubble size
Bubble diameters were estimated using a model based on ultrasound
scattering theory.6,7 This algorithm sizes bubbles based on analysis of
the backscatter intensity of the bubble relative to blood, together with
information on MCA diameter gained for each individual patient from
time-of-flight angiography data, see Supplemental Fig. 1 [7]. Other
adjustable parameters within in the model included Doppler sample
length (8–12 mm), insonation angle (assumed to be 30°), and
haematocrit (recorded every 3 min during CPB). The total volume of air
(V) entering each MCA was calculated using Eq. 1, where ri is the es-
timated radius of each bubble:
∑=V πr
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Since we were unable to exclude solid emboli from our recordings,
any embolic signals generated by solid emboli would have been mis-
classified by this algorithm as very small bubbles. This would not affect
the estimated number, diameter, or volume of macrobubbles, as bub-
bles> 100 μms generate strong backscatter signals that are not con-
fused with particulate emboli. However, misclassification of solid em-
boli as small bubbles does have potential to lower estimates of median
bubble diameter. The total volume of air received would also be slightly
overestimated. For more details of the limitations of our sizing algo-
rithm, please see the feasibility case studies presented by Chung et al.
(2015) [7].
2.1.4. MRI scans
All MRI examinations were conducted using a 3-Tesla whole body
scanner (Magnetom Skyra, Siemens Medical, Erlangen, Germany).
Scans were performed in the following order: 3-plane localiser; diffu-
sion-weighted (DW) imaging; time-of-flight magnetic resonance an-
giography; susceptibility-weighted imaging (SWI), and fluid-attenuated
inversion recovery (FLAIR). FLAIR images were obtained using a slice
thickness of 3 mm with the number of slices set to cover the whole
brain. Matrix size was 320 × 352, field of view was 240 mm, repetition
time/echo time was 6770/108 ms, and inversion time was 2170 ms.
The total imaging time was approximately 30 min. To identify new
CMBs and distinguish chronic lesions from acute ischemic changes, SWI
and FLAIR images were analysed independently by two blinded neu-
roradiologists (JM and AC).
2.1.5. Identification of ischemic lesions and CMBs
FLAIR and DW images were analysed to determine the location and
volume of both new and pre-existing lesions, so that chronic tissue
damage could be distinguished from acute ischemic changes. Image
analysis was performed using the medical image analysis package Jim
(version 7, Xinapse Systems, Colchester, United Kingdom; http://www.
xinapse.com) [9]. Lesions were delineated using a semiautomatic con-
touring technique [9]. SWI images were examined using the Brain
Observer Microbleed Rating Scale to aid identification and location of
CMBs [10]. CMBs were identified as focal areas of low signal on
SWI,< 10 mm in diameter. Symmetrical areas of basal ganglia calci-
fication, flow voids from blood vessels, and low signal from adjacent
bone were excluded. Images were assessed for the location and number
of both new and pre-existing CMBs, which were delineated using the
same semiautomatic contouring technique. New CMBs and FLAIR le-
sions were identified and characterized through registration and sub-
traction of pre- and postoperative images [9]. To aid visualization of the
distribution of new CMBs and FLAIR lesions, postoperative images were
registered to a standard MRI brain atlas [11], and new CMBs and FLAIR
lesions were segmented and displayed using the atlas as a reference for
the 3D display.
2.1.6. Neuropsychological assessment
Neuropsychological testing was performed 1 to 2 weeks before
surgery and 6 to 8 weeks postoperatively (SD, 1.25 weeks), as reported
by Patel et al. 2015 [2]. Our test battery included Trail Making Tests (A
and B) [12], the Grooved Pegboard Test [13], Wechsler Memory Scale-
Third Edition [14], and Wechsler Abbreviated Scale of Intelligence
[15]. Patients also completed a Hospital Anxiety and Depression Scale
questionnaire [16]. The selected battery of tests facilitates pair-wise
analysis of ‘before and after’ scores, and comparison of baseline scores
with well-characterized normative data in age-matched healthy
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controls (analysed via z-score analysis). Neuropsychological assess-
ments were performed by a trained assessor who was blinded to the
bubble sizing data.
2.2. Statistical analysis
Individual neuropsychological test scores were converted to z-scores
through comparison with published data describing the mean (X) and
standard deviation (SD) of test scores measured from a population of
healthy subjects, and mean (x) of test scores measured in our study, Eq.
(2):
=
−z x X
SD (2)
Postoperative z-scores were then subtracted from preoperative z-
scores and a significant decline in cognition was assumed if there was a
drop in z-score of> 1 SD from baseline. For timed tests (Trail Making
A/B and Grooved Pegboard tests), the sign of the z-score was reversed,
so that improved performance corresponded to a positive z-score.
Statistical analyses were performed in R (R Foundation for
Statistical Computing, Vienna, Austria). Median and inter-quartile
range (IQR) are presented where data was non-normally distributed
unless stated otherwise. Comparisons between CABG and valve patients
were performed using a t-test, Mann-Whitney test or Pearson's χ2, as
appropriate. Comparisons between left and right hemispheres were
made using the Chi-squared linear-by-linear association test. After
summarising demographic factors and comparing differences between
CABG and valve surgery, logistic regression was used to model new
CMBs, new ischemic lesions, and POCD as outcome measures: emboli
parameters of interest were introduced one-by-one to assess whether
bubble estimates (number, size, total volume, and shower duration), or
other surgery parameters (type of surgery, CPB time) were associated
with cognitive decline, CMBs, or new lesions. P-values of less than 0.05
were considered statistically significant.
3. Results
A total of 103 patients consented to take part in the study. Thirty
patients did not receive intra-operative TCD monitoring for logistical
reasons. Of the remaining 73 TCD recordings, blinded review suggested
that a further 27 sets of recordings were either incomplete, or of in-
sufficient quality for bubble sizing. A complete flow chart summarising
enrolment and data quality checks can be found in Supplemental Fig. 2.
The study generated a total of 46 pairs of complete bilateral TCD re-
cordings (18 CABG, 28 valve surgery). An analysis summary for in-
dividual patients is provided in Supplemental Table 1. All of the com-
plete sets of TCD recordings were accompanied by pre- and post-
operative MRI scans and neurocognitive assessments. The total number
of patients with SWI imaging was 45.
Manual analysis of 115 h of TCD recordings from 46 patients
identified 92,215 individual embolic signals. Total numbers of emboli
received during surgery varied from 203 signals (patient 11) to 11,646
(patient 45). A representative example showing the timing and esti-
mated sizes of bubbles received during a typical operation is shown in
Fig. 1. Further patient-specific examples can be seen in our preliminary
feasibility study [7].
3.1.1. CABG v valve procedures
The incidence of mild to severe aortic stenosis and duration of
cardiopulmonary bypass were both significantly higher in patients un-
dergoing valve surgery than in CABG patients (p = .016 and p = .006,
respectively), Table 1. In CABG patients, the prevalence of hypercho-
lesterolemia was significantly higher than in valve patients (p = .007),
Table 1. Otherwise, demographic factors, such as age, were similar
between procedure types.
Surgery-related CMBs were significantly more common after valve
surgery (82%) than after CABG (57%), p = .03, Table 2. Although a
higher proportion of valve patients (43%) also acquired new MRI le-
sions compared to 33% of CABG patients, this difference was not sig-
nificant, p = .55, Table 2. Fewer valve patients (43%) exhibited POCD
compared to CABG patients (50%), p= .76, but this difference was also
not significant, Table 2.
Patients undergoing valve procedures received more than twice as
many bubbles per procedure [median: 1995 vs. 859, p = .004], and
seven times as many macro-bubbles [median: 218 vs. 28, p = .001] as
CABG patients. The total volume of bubbles experienced was 31 times
higher for valve surgery than CABG [p = .005], Table 2. The median
[IQR] number of emboli observed following the release of the AxC was
significantly higher in patients undergoing valve surgery (39 [7–90])
compared to CABG (6 [2–25]), p = .03, Table 2. Median estimated
bubble diameter was not significantly different between procedure
types (20–30 μm), p = .82, Table 2.
Overall, significantly higher incidences of CMBs were observed
following valve surgery, potentially linked to the release of ather-
omatous debris following release of the AxC, longer CPB times, and a
higher number, size and volume of bubbles. Conversely, we found no
evidence of any difference in the incidence of new MRI lesions and
POCD between CABG and valve procedures.
3.1.2. Contributors to CMBs
Patients undergoing valve surgery were significantly more likely to
experience new CMBs compared to CABG, p = .03. Logistic regression
analysis estimated an increase in the odds of acquiring new CMBs of 6%
[95% CI: 1 to 12%] for every minute of bypass time over 91 mins.
Patients receiving new CMBs experienced longer CPB machine times,
on average, (mean, SD: 99 ± 53 mins) than patients with no new
CMBs (71 ± 22 mins), p = .02, Table 3. The odds of acquiring new
CMBs also increased by approximately 5% [95% CI: 1 to 10%] for every
embolus detected in the first minute after the release of the AxC. The
relationship between new CMBs and total number of emboli was of
borderline significance (p = .06, Table 4). However, other factors re-
lating to bubble size and volume were either non-significant, or the
odds ratio included 1, which implies there may be no difference.
3.1.3. Contributors to ischemic lesions
The median number of emboli detected in the first minute following
release of the aortic cross-clamp was significantly higher in patients
with new ischemic lesions (46 emboli [IQR: 11–102]) compared to
patients with no new lesions (8 emboli [IQR: 0–39], p = .04), Table 3.
Logistic regression analysis with new lesions as the outcome revealed
an increase in odds of acquiring new ischæmic lesions of 4% [95% CI: 1
to 7%] for every minute of bypass time over 91 mins (p= .01), Table 4.
The odds of acquiring new ischemic lesions increased by approximately
3% [95% CI: 1 to 10%] for every embolus detected during the first
minute following the release of the AxC (p = .02), Table 4.
3.1.4. Contributors to cognitive decline
Advanced age was the only significant factor associated with POCD
(t-test: p= .01), Table 4. This is consistent with the findings of previous
research [17]. Our data provided no evidence for any relationship be-
tween emboli or bubble properties and POCD, Table 3. In our logistic
regression analysis with POCD as an outcome, the odds of experiencing
POCD were estimated to increase with age by 11% [95% CI: 2 to 22%]
for every year of age above the age of 64, Table 4. On entering bubble
properties into an exploratory logistic regression model of POCD; all
odds ratio estimates were either non-significant or bounded by a
narrow 95% confidence interval centred on ‘1’ suggesting additional
bubbles confer no obvious increase (or decrease) in the risk of POCD,
regardless of properties.
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3.1.5. Bubble properties
The volume of air typically received during both valve and CABG
surgery were estimated to be less than 0.03 mL in all cases. Overall,
only 13% of the 92,215 bubbles analysed were classified as macro-
bubbles, defined as greater than 0.1 mm in diameter. Dense showers
containing particularly large bubbles were observed following release
of the aortic cross-clamp during valve procedures, and lasted a median
duration of 28 s [IQR: 0–99]; no prolonged showers were observed
during CABG, p = .001 (Table 2).
3.1.6. Distribution of CMBs and new ischemic lesions
Overall, there was no significant difference in the number of CMBs
observed in the left brain hemisphere (n = 116) compared to the right
(n= 95), p= .23, Table 5, Fig. 2A. The highest numbers of CMBs were
observed in the MCA territory, which is consistent with previous studies
[18,19]. Similar numbers of bubbles and accumulated volume of air
were detected in the left MCA (total: 49,485 (54%), median [IQR], 20
[1−10] μL) and the right MCA (total: 42,730 (46%), 20 [1–10] μL), see
Table 5.
The total number of ischemic FLAIR lesions was more than double
in the left hemisphere (n = 19) compared to the right (n = 7, p = .05)
with the majority of the lesions in the MCA region, Table 5, Fig. 2B. The
total number of emboli detected 1 min after application and release of
the AxC was also higher in the left MCA compared to the right, though
this was not statistically significant (AxC on: p = .09 and AxC off:
p = .41), Table 5, Fig. 2B. Similarly to the distribution of CMBs, the
majority of ischemic lesions were observed in the anterior/frontal re-
gions of the brain with fewer in the posterior regions.
4. Discussion
This study uses a novel bubble sizing algorithm to quantify the
number and sizes of bubbles released into the cerebral circulation
during cardiac surgery, and provides a first exploratory analysis in-
vestigating whether bubbles increase the risk of new CMBs, ischemic
lesions, or POCD. As might be expected for patients with valve disease,
valve patients had a significantly higher incidence of aortic stenosis,
whereas CABG patients had a higher incidence of hypercholester-
olemia. Valve patients were at significantly higher risk of acquiring new
CMBs, and both valve surgery and new CMBs were associated with
longer CPB duration and number of emboli detected 1 min after the
release of the AxC. Although valve surgery was also associated with a
higher number and volume of macrobubbles, these were not sig-
nificantly independently associated with new CMBs.
Fig. 1. Bubble diameters estimated for a 55 year old male undergoing aortic valve replacement who had pre-existing cerebrovascular disease (total lesion volume:
1876 mm3) but no pre-existing CMBs. This patient exhibited cognitive decline in 2/8 tests with 10 new CMBs but no new ischemic lesions. Markers denote individual
emboli (blue: left MCA events, orange: right MCA events). The vertical axis and marker size reflect estimated bubble diameter [7]. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
Table 1
Clinical and demographic characteristics of patients undergoing CABG and
valve surgery.
CABG
(n = 18)
Valve
(n = 28)
p-value
Men:women 16:2 27:1 0.552*
Age, y, mean (SD) 66 (7) 62 (9) 0.150†
CPB time, mins, mean (SD) 60 (22) 101 (57) 0.006†
Mean arterial blood pressure, mmHg, mean
(SD)
64 (9) 61 (8) 0.208†
Mean haematocrit, %, mean (SD) 29 (4) 29 (4) 0.792†
Smoking, n (%) 8 (44) 13 (46) 0.895‡
Treated hypertension, n (%) 16 (88) 18 (64) 0.090*
Hypercholesterolemia, n (%) 18 (100) 19 (67) 0.007*
Ischemic heart disease, n (%) 11 (61) 12 (42) 0.227‡
Aortic stenosis (mild/severe), n (%) 5 (27) 18 (64) 0.016‡
Pre-existing WMD, cm3, mean (SD) 739 (1065) 2047 (5322) 0.217†
No. of old CMBs, n, mean (SD) 1 (1) 6 (9) 0.281†
Post-op stroke, n (%) 2 (11) 3 (16) 1.000*
Probable CAA, n (%) 2 (11) 3 (16) 1.000*
Values reported are mean (SD) or count (%) or in a ratio format. *Fisher exact-
test, †t-test, ‡χ2 test. CMB indicates cerebral microbleeds; CPB indicates car-
diopulmonary bypass; WMD indicates white matter disease; CAA indicates
cerebral amyloid angiopathy.
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4.1.1. Pathophysiology of new CMBs
Bubbles have potential to initiate an inflammatory response asso-
ciated with activation of the complement system [4]. One hypothesis
describing the pathogenesis of CMBs is that endothelial disruption,
combined with other factors such as anticoagulation, blood viscosity
changes, perfusion mismatch during surgery, or inflammation, can lead
to localized Blood Brain Barrier leakage resulting in numerous small
CMBs detected by MRI. Our bubble sizing analysis suggest a wide range
of bubble diameters entering the cerebral circulation during cardiac
surgery, with a median diameter of 20–40 μm.
In previous independent post-mortem examinations of the brains of
patients who died shortly after cardiac surgery, Moody et al., observed
highly numerous ‘sausage shaped’ arteriolar dilatations ranging be-
tween 10 and 70 μm in diameter [20]. They describe these dilations as
occurring only in arterioles rather than veins [20] and report ap-
proximately 30–40 dilatations per cm2 in 100 μm thick sections of the
basal ganglia< 4 days after surgery, reducing to 1–2 dilatations per
cm2 in patients who died a week later [20]. No dilatations were ob-
served in patients who did not undergo CPB and no difference in the
density of dilatations were identified between valve and CABG surgery.
Our finding that new CMBs were associated with longer CPB duration,
with no difference between procedure types, may be consistent with
previous post-mortem data.
However, Moody et al. were unable to reproduce dilatations
through injection of a bubble mixture to an animal bypass model [21].
Based on histological staining, they concluded that the numerous di-
latations they observed in brain tissue must be due to lipid emboli [22].
Unfortunately, our embolus analysis techniques are currently unable to
distinguish lipid from air emboli, and therefore a link between lipid
emboli, small arteriolar dilatations and CMBs has yet to be clearly es-
tablished.
One explanation for the pathogenesis of surgery-related CMBs is
that bubbles last sufficiently long in the brain's circulation to lead to
endothelial disruption, which when combined with other factors, such
as anticoagulation, blood viscosity changes, perfusion mismatch during
surgery, accumulation of lipids, and inflammation, could lead to loca-
lized Blood Brain Barrier leakage resulting in widespread small CMBs,
some of which become large enough to be visible in MRI scans. It is
important to establish whether the pathogenesis of surgery-related
CMBs differs from that of chronic CMBs related to cerebral amyloid
angiopathy, since the presence of CMBs is considered to be a contra-
indication for prescription of anticoagulant medication. Further re-
search would be of interest to confirm whether circulating bubbles or
lipids provide a plausible explanation for the pathogenesis of surgery-
related CMBs.
4.1.2. Causes of new ischemic lesions
In the current study, CPB time and emboli detected 1 min after AxC
removal were significant predictors for new ischemic lesions. Focal
cerebral ischemic injury is not a rare consequence of cardiac surgery,
and new lesions were found in 39% of our cohort following surgery.
The association with AxC emboli is consistent with the release of
atheromatous debris, as described in several previous research studies
[23]. Although patients with new MRI lesions tended to receive a larger
volume of air, higher number of macro-bubbles, and experience longer
shower durations these trends did not reach statistical significance. Our
study was therefore unable to rule out air emboli as a contributory
factor for new ischemic lesions. The number of emboli detected 1 min
Table 2
Comparison of imaging findings, cognitive outcome, and bubble parameters between CABG and valve surgery.
CABG
(n = 18)
Valve
(n = 28)
p-value
New cerebral microbleeds, n (%) 10 (57) 23 (82) 0.031⁎
New FLAIR MRI lesions, n (%) 6 (33) 12 (43) 0.557⁎
Neuropsychological decline, n (%) 9 (50) 12 (43) 0.764⁎
Total emboli, n (IQR) 859 (625–1442) 1995 (1077–3127) 0.004†
Emboli: 1 min after removal of AxC, n (IQR) 6 (2–25) 39 (7–90) 0.034†
Macro-bubbles: ≥0.1 mm, n (IQR) 28 (18–108) 218 (138–505) 0.001†
Shower duration, seconds, n (IQR) 0 (0–2) 28 (0–99) 0.001†
Median bubble diameter, μm, n (IQR) 20 (10−30) 20 (20–40) 0.821†
Total volume of air, μL, n (IQR) 0.4 (0–5) 12.6 (3–26) 0.005†
Values reported are median (IQR) Interquartile Range (25th – 75th percentile).*Chi-squared test, †Mann-Whitney U test.
Table 3
Univariate comparison of age, total number of emboli, number of macro (> 0.1 mm) bubbles, number of emboli released following removal of the aortic cross-clamp,
shower duration, bubble diameter and volume of air for patients with and without new CMBs, MRI lesions, and cognitive decline.
No new
CMBs
New
CMBs p-value
No new
MRI lesions
New
MRI lesions p-value
No cognitive
decline
Cognitive
decline p-value
n = 12 n = 33 n = 28 n = 18 n = 25 n = 21
Age, years (range) 68 (46–78) 64 (41–80) 0.16* 64 (41–77) 66 (46–80) 0.57* 62 (41–77) 68 (54–80) 0.02*
Mean CPB time, mins, mean
(SD)
71 (22) 99 (53) 0.02* 98 (58) 80 (23) 0.15* 94 (50) 87 (47) 0.59*
Total emboli, n (IQR) 1094
(818–1884)
1476
(731–2758)
0.35† 1073
(667–2070)
1761
(1087–2480)
0.13† 1357 (729–2453) 1349
(870–2096)
0.84†
Macro-bubbles: ≥0.1 mm, n
(IQR)
157 (20–249) 169 (35–363) 0.52† 131 (26–327) 171 (112–316) 0.49† 194 (55–324) 132 (22–335) 0.33†
Emboli: 1 min after removal of
AxC, n (IQR)
6.5 (0–38) 6.0 (0−32) 0.66† 8 (0–39) 46 (11−102) 0.04† 12 (4–68) 23 (2–75) 0.84†
Shower duration, seconds (IQR) 0 (0–81) 10 (0–63) 0.44† 2 (0–35) 11 (0–104) 0.45† 10 (0–52) 0 (0–82) 0.99†
Total volume of air, μL (IQR) 1.7 (0.2–20) 7 (1.1–21.6) 0.38† 5.3 (0.2–18.1) 6.2 (1.5–28) 0.37† 7.4 (1.5–26) 2.4 (0.2–19) 0.26†
CABG: intra-cardiac procedures 8:4 10:23 0.02‡ 12:16 6:12 0.52‡ 9:16 9:12 0.76‡
Values reported are mean (SD) and median (IQR) Interquartile Range (25th – 75th percentile). Age reported as mean (range). CPB; cardiopulmonary bypass, CMBs;
cerebral microbleeds, CABG indicates coronary artery bypass grafting; AxC; Aortic cross-clamp. *t-test, †Mann-Whitney U test, ‡Chi-squared test.
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after AxC was higher in the left MCA compared to the right which was
consistent with the greater numbers of new ischemic lesions observed in
the left hemisphere. Although the number of new lesions was higher in
the left hemisphere, the volume of new lesions was higher in the right
hemisphere. This distribution in number and volume of new lesions is
consistent with a cardio-embolic pathogenesis with larger emboli
tending to disproportionately favour major vessels [24].
4.1.3. Causes of post-operative cognitive decline
Overall, we found a 45% incidence of POCD assessed 7 weeks post-
operatively, which is similar to levels reported elsewhere [25–27]. Our
exploratory logistic regression analysis confirmed previous reports of a
Table 4
Binomial logistic regression analysis for outcomes of new CMBs, new ischemic lesions, and cognitive decline.
New
CMBs p-value
New
MRI lesions p-value
Cognitive
decline p-value
OR (95% CI) OR (95% CI) OR (95% CI)
Age, years 0.97 (0.87–1.08) 0.57 0.97 (0.89–1.01) 0.50 1.11 (1.02–1.22) 0.01
CPB time, mins 1.06 (1.01–1.12) 0.03 0.96 (0.93–0.99) 0.01 1.00 (0.98–1.01) 0.99
Total emboli, n 1.00 (1.00–1.02) 0.06 1.00 (1.00–1.01) 0.50 1.00 (1.00–1.00) 0.49
Emboli: 1 min after removal of AxC, n 0.95 (0.90–0.99) 0.03 1.03 (1.00–1.10) 0.02 0.98 (0.96–1.00) 0.19
Logistic regression analyses controlling for effects of age and sex. Values presented as OR and 95% CIs. CMBs indicates cerebral microbleeds; CPB; cardiopulmonary
bypass; AxC; Aortic cross-clamp.
Table 5
Left and right hemispheric distribution of new CMBs, new ischemic lesions, and emboli entering the left and right cerebral MCA territories.
Left cerebral territory Right cerebral territory P-value
Total emboli, n (IQR) 655 (387–1424) 671 (370–1130) 0.51*
Estimated volume of air, μm, n (IQR) 0.02 (0.001–0.01) 0.02 (0.001–0.01) 0.71*
Emboli 1 min after AxC on, n (IQR) 7.5 (1−23) 4.5 (0–16) 0.09*
Emboli 1 min after AxC off, n (IQR) 8 (2–40) 6 (0−31) 0.41*
Total MRI FLAIR ischemic lesions, n 19 7 0.05*
Volume of MRI FLAIR lesions, mm3, mean (SD) 38 (103) 50 (213) 0.72*
Middle cerebral artery (n) 15 4 0.07*
Anterior cerebral artery (n) 1 2 –
Posterior cerebral artery (n) 2 1 –
Superior cerebellar artery (n) 1 0 –
Total SWI Cerebral microbleeds 116 95 0.23*
Middle cerebral artery (n) 58 38 0.29*
Anterior cerebral artery (n) 24 32 0.60*
Posterior cerebral artery (n) 32 23 0.49*
Superior cerebellar artery (n) 2 2 –
Values reported are median (IQR) Interquartile Range (25th – 75th percentile) and mean (SD). AxC; Aortic cross-clamp, FLAIR; Fluid attenuated inversion recovery,
SWI; Susceptible weighted imaging, *Chi-squared Linear-by-Linear Association test.
Fig. 2. Positions of (A) new cerebral microbleeds,
and (B) new MRI FLAIR lesions seen in the combined
imaging data for all 46 patients. Only 4 new lesions
were observed in the right hemisphere MCA territory
compared to 14 in the left MCA territory; consistent
with fewer emboli identified entering the right MCA
in the 1 min following release of the AxC (right: 601
emboli, vs. left 1247 emboli). A similar observation
was made for the CMBs, with 38 found in the right
MCA territory and 58 in the left MCA territory.
Estimated total numbers of bubbles and volume of
air entering the MCA territories were similar for both
hemispheres.
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link between advanced age and risk of POCD [27–29], but found no
evidence to support the hypothesis that bubbles, or any other surgical
factor such as procedure type or duration of CPB, contribute to an in-
creased risk of developing POCD.
4.1.4. Limitations of this study
A major limitation of our study is its small sample size. We initially
set out to detect bubbles in over 100 patients, which would have offered
sufficient statistical power to identify a ~ 20% difference between
groups. Technical problems with our TCD recordings vastly reduced our
sample size, see Supplemental Fig. 2. A study powered to confirm the
10% difference in the incidence of POCD and MRI lesions between
procedure types identified in our cohort would require around 500
patients.
A technical limitation is that no technology currently exists to re-
liably distinguish between thrombus, lipid, and gaseous emboli [30]; so
any weak embolic signals from lipids or thrombus particles would have
been misclassified by our sizing algorithm as small bubbles. Mis-
classification of thrombus and lipid emboli as small bubbles will have
influenced our bubble parameter estimates, and limits our ability to
draw firm conclusions relating to the separate contributions of
thrombus, lipid and gas emboli to cognitive and MRI outcomes.
The presence of dense showers of bubbles during valve procedures
also made it difficult to detect and size individual emboli during some
parts of the procedure. The total number of emboli and volume of air
entering the circulation reported during valve procedures was therefore
likely to be underestimated. There are several potential sources of in-
accuracy in our estimates of bubble size, which are particularly sensi-
tive to uncertainties in MCA diameter. To reduce these errors, every
effort was made to accurately measure MCA diameter and to optimise
the TCD signal.
5. Conclusions
The main novelty of this study lies in our quantification of the total
number and sizes of bubbles received throughout cardiac surgery. We
used this to explore whether large bubbles or cumulative volume of air,
might be influential in the development of new CMBs, ischemic MR
lesions, or POCD. Although our study does provide new information
about the properties and numbers of bubbles entering the brain during
surgery, we found no evidence of a link between large numbers of
macrobubbles and adverse cognitive or MR outcome.
Valve patients received more CMBs; averaging 6.6 new CMBs per
patient compared to 1.2 new CMBs following CABG. Valve patients also
received a significantly higher estimated volume of bubbles, and had
longer CPB times than patients undergoing CABG. Patients with higher
numbers of emboli detected in the first minute following release of the
aortic cross-clamp were more likely to receive new ischemic lesions,
explained by the release of atheromatous debris. Our study confirmed
previous findings that POCD tends to occur in elderly subjects. POCD
did not appear to be significantly linked to the procedure types studied
here (valve replacement/repair or CABG) or operative parameters.
Based on these hypothesis-generating findings, we propose that bubbles
may play a role in the pathogenesis of small arteriolar dilatations and
surgery-related CMBs.
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